Structure-activity relationships of tariquidar analogs as multidrug resistance modulators. - Wikidata - awgldk - TriplyDB

Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.

Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.

http://www.wikidata.org/entity/Q37510736

about

Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review.Structure-activity relationships and in silico models of P-glycoprotein (ABCB1) inhibitors.Probenecid is a chemosensitizer in cancer cell lines.Image-Based Analysis to Predict the Activity of Tariquidar Analogs as P-Glycoprotein Inhibitors: The Importance of External Validation.

P2860

Q34581006-1ABF726B-70C8-49E0-A8EC-99425A958048 Q34768677-D2D8EF2F-1B73-4818-9191-E22F6B1331B1 Q34940694-5E6E8694-9FF4-41B8-BADB-D14403DD484C Q36604036-7974A9E9-0EC4-4A6A-BC6E-408F44E3054E Q37854074-07C8CE02-716F-4D9D-84F3-87BB86D145F2 Q38101682-02BCD9F4-2185-45D0-8654-EA8E173ED6BA Q39485986-6B18E5C9-80F4-48AB-A2BC-CCC4334CB078 Q50748142-422E4A24-F22F-4E10-913B-EC4AA82C94F4

P2860

Structure-activity relationships of tariquidar analogs as multidrug resistance modulators.

http://www.wikidata.org/entity/Q37510736

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Structure-activity relationshi ...... ltidrug resistance modulators.

@en

Structure-activity relationshi ...... ltidrug resistance modulators.

@nl

type

label

Structure-activity relationshi ...... ltidrug resistance modulators.

@en

Structure-activity relationshi ...... ltidrug resistance modulators.

@nl

prefLabel

Structure-activity relationshi ...... ltidrug resistance modulators.

@en

Structure-activity relationshi ...... ltidrug resistance modulators.

@nl

P1433

Q37510736-F35A55A1-9EEA-4B85-8696-DCE8597900B5

P1476

Q37510736-6E6D085C-763E-4641-B342-62C8645FBB77

P2093

Q37510736-40AB3BCE-F0F5-4A7D-A79B-F08993879176

Q37510736-5A98DF51-718A-4D49-B7CC-E9FD5DACD6A3

P2860

Q37510736-0025AB3C-F267-41D9-B146-22947B527F2B

Q37510736-097295A7-AEB2-46DF-8697-36CF0F5DEAAD

Q37510736-146B67C8-495C-4EBA-A3D0-D8478EB39E53

Q37510736-20C8528F-6CF8-4224-876E-949738B81740

Q37510736-24CA1C33-25F6-49AF-B626-51812BB27D48

Q37510736-2935BE79-EF9C-4D12-8E27-4AA4ED8363DF

Q37510736-2BF58900-1FD0-410F-AC76-8D33F12581A1

Q37510736-34114064-68EE-4666-9429-4621ABA391DF

Q37510736-35FEFC06-7394-4B80-B59A-D5E7561E7ADF

Q37510736-39102683-13F3-4B30-A89F-D03712D66602

P2888

Q37510736-7B0A06BD-DC40-4B7F-BF31-1D51C56A7C2A

P304

Q37510736-3CED8B19-99B6-49DB-A2BD-69A5CB950FDF

P31

Q37510736-B2D32226-4587-48DD-9944-178397AC25A3

P356

Q37510736-98FDD13B-BE1D-488D-9467-5BD9E79CBA3F

P407

Q37510736-849E1E5A-9383-460D-9175-6110F5BF4ACA

P433

Q37510736-7582CDC2-66DF-44D5-BEC8-CB29B51318BA

P478

Q37510736-57CC9340-646B-405F-B98C-A91AA733B2F7

P577

Q37510736-993572EE-5C6A-4032-9CD7-501E24B1350B

P5875

Q37510736-2158524E-BD08-4A13-B3F0-404186FFD5EE

P6179

Q37510736-D709A8D9-7969-476C-B6DB-A87846CDAAC7

P698

Q37510736-5EB1348A-0BCF-4C75-B21A-84891A376DCB

P921

Q37510736-D78948A0-E35A-4853-A1B1-9F24196856C8

P932

Q37510736-E3A9A18A-08CB-42C3-A66E-060F05B297B9

P356

S12248-009-9118-Z

P1433

The AAPS Journal

P1476

Structure-activity relationshi ...... ltidrug resistance modulators.

@en

P2093

Ilza K Pajeva

http://www.w3.org/2001/XMLSchema#string

Michael Wiese

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Biochemistry of multidrug resistance mediated by the multidrug transporter

Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein

In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.

Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.

Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.

Structure-function relationships of multidrug resistance P-glycoprotein.

Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators.

New functional assay of P-glycoprotein activity using Hoechst 33342.

Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.

P2888

s12248-009-9118-z

P304

435-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1208/S12248-009-9118-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26274046

http://www.w3.org/2001/XMLSchema#string

P6179

1009900600

http://www.w3.org/2001/XMLSchema#string

P698

19504188

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

2758111

http://www.w3.org/2001/XMLSchema#string